HRTX: Heron Therapeutics Inc Company Profile & Statistics

About

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.

Info & Links

CEO

Craig Collard

Headquarters

4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO, CA 92121, UNITED STATES

Auditor

TerSera Therapeutics LLC

Share holders

Employees

126

Heron Therapeutics Inc Statistics

Valuation Measures

Market Capitalization²

244.12M

Enterprise Value

392.85M

Enterprise Value/EBITDA(ttm)

-15.85

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.77

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

72.19%

Operating Margin(ttm)

-20.31%

Profit Margin(ttm)

-20.21%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-20.31%

Return on Assets(ttm)

-12.72%

Income Statement

Revenue(ttm)

137.74M

Revenue Per Share(ttm)

0.91

Gross Profit(ttm)

99.43M

EBITDA(ttm)³

-24.79M

Net Income Available to Common(ttm)

-27.97M

Diluted EPS(ttm)

-0.18

Share Statistics

Beta (5Y Monthly)

1.67

52-Week Change

7.00%

S&P 500 52-Week Change

25.93%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

152.09M

Dividend Yield

0.00%

Float⁴

143.33M

% Held by Insiders

5.76%

% Held by Institutions

80.01%

Balance Sheet

Total Cash(mrq)

70.89M

Total Cash Per Share(mrq)

0.47

Total Debt(mrq)

174.47M

Total Debt/Equity(mrq)

-436.13%

Current Ratio(mrq)

2.28%

Quick Ratio(mrq)

1.74%

Book Value Per Share(mrq)

-0.26

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.07

Free Cash Flow(ytd)

-11.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HRTX

Heron Therapeutics Inc

Heron Therapeutics Inc Profile